What changed
MHRA authorized a higher maximum Wegovy dose for adults with obesity on January 6; its explanatory story was published January 16.
What the evidence does not settle
Some other groups and indications are excluded. This is not a U.S. labeling change or a dosing instruction.
Evidence record
Event date: 2026-01-06. Source review: inherited source synthesis; not re-audited in this expansion. Editorial publication: 2026-10-29. Original source links below retain their publication dates. These dates are not interchangeable. This is targeted source synthesis, not an exhaustive archive or a qualified clinical/legal review.
Revision history
29 October 2026: migrated from the research edition, retaining source links and evidence qualifications; not re-audited in the current expansion. Report a proposed correction through Contact us; do not include patient data.